214 related articles for article (PubMed ID: 26574782)
1. MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases.
Saghazadeh A; Rezaei N
Expert Rev Neurother; 2022 Jun; 22(6):427-453. PubMed ID: 26574782
[TBL] [Abstract][Full Text] [Related]
2. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
[TBL] [Abstract][Full Text] [Related]
3. Regulatory miRNA-mRNA Networks in Parkinson's Disease.
Santos-Lobato BL; Vidal AF; Ribeiro-Dos-Santos Â
Cells; 2021 Jun; 10(6):. PubMed ID: 34204164
[TBL] [Abstract][Full Text] [Related]
4. Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review).
Ma Z; Liang H; Hu B; Cai S; Yan D
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37144489
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.
Wang H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799467
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
Duarte FV; Palmeira CM; Rolo AP
Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and microRNAs - Lessons from model organisms and human studies.
Evans B; Furlong HA; de Lencastre A
Exp Gerontol; 2021 Nov; 155():111585. PubMed ID: 34634413
[TBL] [Abstract][Full Text] [Related]
8. The role of microRNA-485 in neurodegenerative diseases.
Ryu IS; Kim DH; Cho HJ; Ryu JH
Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
Weng YT; Chang YM; Chern Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.
Tryphena KP; Anuradha U; Kumar R; Rajan S; Srivastava S; Singh SB; Khatri DK
J Alzheimers Dis; 2023; 94(s1):S187-S202. PubMed ID: 35848027
[TBL] [Abstract][Full Text] [Related]
11. A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease.
Szelągowski A; Kozakiewicz M
Oxid Med Cell Longev; 2023; 2023():7759053. PubMed ID: 37333462
[TBL] [Abstract][Full Text] [Related]
12. Systemic Analysis of miRNAs in PD Stress Condition: miR-5701 Modulates Mitochondrial-Lysosomal Cross Talk to Regulate Neuronal Death.
Prajapati P; Sripada L; Singh K; Roy M; Bhatelia K; Dalwadi P; Singh R
Mol Neurobiol; 2018 Jun; 55(6):4689-4701. PubMed ID: 28710704
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in neurodegeneration induced by environmental neurotoxicants and aging.
Singh T; Yadav S
Ageing Res Rev; 2020 Jul; 60():101068. PubMed ID: 32283224
[TBL] [Abstract][Full Text] [Related]
14. Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics.
Uppala SN; Tryphena KP; Naren P; Srivastava S; Singh SB; Khatri DK
Mech Ageing Dev; 2023 Jul; 213():111826. PubMed ID: 37268278
[TBL] [Abstract][Full Text] [Related]
15. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
[TBL] [Abstract][Full Text] [Related]
16. Modified level of miR-376a is associated with Parkinson's disease.
Baghi M; Rostamian Delavar M; Yadegari E; Peymani M; Pozo D; Hossein Nasr-Esfahani M; Ghaedi K
J Cell Mol Med; 2020 Feb; 24(4):2622-2634. PubMed ID: 31930701
[TBL] [Abstract][Full Text] [Related]
17. microRNAs and Neurodegenerative Diseases.
Qiu L; Tan EK; Zeng L
Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
[TBL] [Abstract][Full Text] [Related]
18. Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
Oliveira SR; Dionísio PA; Correia Guedes L; Gonçalves N; Coelho M; Rosa MM; Amaral JD; Ferreira JJ; Rodrigues CMP
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585840
[TBL] [Abstract][Full Text] [Related]
19. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
[TBL] [Abstract][Full Text] [Related]
20. The roles of non-coding RNAs in Parkinson's disease.
Majidinia M; Mihanfar A; Rahbarghazi R; Nourazarian A; Bagca B; Avci ÇB
Mol Biol Rep; 2016 Nov; 43(11):1193-1204. PubMed ID: 27492082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]